Back to search

Article

Transportability of patient outcomes from a US clinical trial to real-world populations - a case study using Lung-MAP S1400I (NCT02785952)

2024-05-27

Abstract excerpt

2. <h4>Background</h4> The external validity of results from clinical trials to routine clinical practice is often questioned. This is sometimes because certain real world patient groups are excluded or underrepresented in clinical trials, or because standards of care in trials are different from those in real-world populations globally. This lack of external validity of trial results manifests as an efficacy-effe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3527f4eb-e594-5280-9290-7af2b6f446d8
DOI
10.1101/2024.05.25.24307916
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Transportability of patient outcomes from a US clinical trial to real-world populations - a case study using Lung-MAP S1400I (NCT02785952)DOI 10.1101/2024.05.25.24307916
Global Transportability of Clinical Trial Outcomes to Real-World Lung Cancer Populations A case Study using Lung-MAP S1400ISemantic proximity
Real-World Data and Evidence in Lung Cancer: A Review of Recent DevelopmentsSemantic proximity
External Control Arm with Synthetic Real-world Data for Comparative Oncology using Single Trial Arm Evidence (ECLIPSE): A Case Study using Lung-MAP S1400ISemantic proximity
A Community Challenge to Predict Clinical Outcomes After Immune Checkpoint Blockade in Non-Small Cell Lung CancerSemantic proximity
Extending Inferences From A Real-world Clinico-Genomic Database Non-Small Cell Lung Cancer Sample To The Underlying Target Population Using Combined Information From Cancer RegistrationsSemantic proximity
Survival benefit in EGFR-wild and ALK negative NSCLC patients who participate in clinical trials compared to standard-of-care: Propensity-matched analysis.Semantic proximity
Extending Inferences From A Real-world Clinico-Genomic Database Non-Small Cell Lung Cancer Sample To The Underlying Target Population Using Combined Information From Cancer RegistrationsSemantic proximity
Effectiveness and Durable Outcomes with Second-Line Immunotherapy in Advanced NSCLC in Real World Practice in IndiaSemantic proximity
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic or Unresectable EGFR-Mutated Non-Small Cell Lung Cancer Previously Treated with Osimertinib and Platinum-Based Chemotherapy.Semantic proximity
Comparative effectiveness of first line pembrolizumab vs. chemotherapy in aNSCLC: A Norwegian Population-Based Cohort StudySemantic proximity
Trastuzumab deruxtecan in HER2-mutant non-small-cell lung cancer: a plain language summary of the DESTINY-Lung01 study.Semantic proximity
Comparative effectiveness of mobocertinib and standard of care in patients with NSCLC with EGFR exon 20 insertion mutations: An indirect comparison.Semantic proximity
Select a neighboring publication to make it the new centre.